The first Clovis Oncology trade was made in Q1 2019.
Since then Mario Gabelli bought shares seven more times and sold shares on eight occasions. The investor completely sold their stake between Q2 2022 and Q4 2022.
Avg closing price
Price range
Sold -145 Thousand shares
Q4 2022
Avg closing price
$0.66
Price range
$0.08
-
$1.30
Sold 8.2% shares (-13 Thousand shares)
Q3 2022
Avg closing price
$1.56
Price range
$1.05
-
$2.85
Sold 8.5% shares (-14.7 Thousand shares)
Q2 2022
Avg closing price
$1.48
Price range
$0.63
-
$2.96
Increased shares by 3.0% (+5 Thousand shares)
Q1 2022
Avg closing price
$1.96
Price range
$1.43
-
$3.14
Sold 14.4% shares (-28.3 Thousand shares)
Q4 2021
Avg closing price
$3.70
Price range
$2.70
-
$4.76
Sold 4.4% shares (-9 Thousand shares)
Q3 2021
Avg closing price
$4.82
Price range
$4.06
-
$5.80
Increased shares by 4.0% (+7.85 Thousand shares)
Q2 2021
Avg closing price
$5.86
Price range
$5.02
-
$7.05
Sold 38.4% shares (-123 Thousand shares)
Q1 2021
Avg closing price
$6.70
Price range
$4.81
-
$10.34
Increased shares by 2.6% (+8.15 Thousand shares)
Q4 2020
Avg closing price
$5.06
Price range
$4.13
-
$6.41
Sold 2.4% shares (-7.6 Thousand shares)
Q3 2020
Avg closing price
$5.98
Price range
$4.82
-
$7.72
Increased shares by 2.7% (+8.3 Thousand shares)
Q2 2020
Avg closing price
$7.57
Price range
$5.69
-
$9.69
Increased shares by 1.3% (+3.97 Thousand shares)
Q1 2020
Avg closing price
$8.02
Price range
$3.77
-
$11.00
Sold 16.7% shares (-61.7 Thousand shares)
Q4 2019
Avg closing price
$7.27
Price range
$3.00
-
$16.43
Increased shares by 85.1% (+170 Thousand shares)
Q3 2019
Avg closing price
$8.09
Price range
$3.93
-
$15.35
Increased shares by 264.8% (+145 Thousand shares)
Q2 2019